399 related articles for article (PubMed ID: 26970127)
1. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.
Neto AG; Whitaker A; Pei Z
Semin Oncol; 2016 Feb; 43(1):86-96. PubMed ID: 26970127
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
Snider EJ; Freedberg DE; Abrams JA
Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
Yang L; Francois F; Pei Z
Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
[TBL] [Abstract][Full Text] [Related]
6. Microbiome in reflux disorders and esophageal adenocarcinoma.
Yang L; Chaudhary N; Baghdadi J; Pei Z
Cancer J; 2014; 20(3):207-10. PubMed ID: 24855009
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
Dunbar KB; Souza RF; Spechler SJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
[TBL] [Abstract][Full Text] [Related]
8. [Chemoprevention in adenocarcinoma of the esophagus].
Lanas A; Alcedo González J
Acta Gastroenterol Latinoam; 2007 Mar; 37(1):37-48. PubMed ID: 17486744
[TBL] [Abstract][Full Text] [Related]
9. The Esophageal Microbiome in Health and Disease.
Corning B; Copland AP; Frye JW
Curr Gastroenterol Rep; 2018 Aug; 20(8):39. PubMed ID: 30069679
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
13. Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma.
Hao Y; Karaoz U; Yang L; Yachimski PS; Tseng W; Nossa CW; Ye W; Tseng M; Poles M; Francois F; Traube M; Brown SM; Chen Y; Torralba M; Peek RM; Brodie EL; Pei Z
Int J Cancer; 2022 Nov; 151(10):1703-1716. PubMed ID: 35751398
[TBL] [Abstract][Full Text] [Related]
14. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
15. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
16. A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection.
Kountouras J; Doulberis M; Papaefthymiou A; Polyzos SA; Vardaka E; Tzivras D; Dardiotis E; Deretzi G; Giartza-Taxidou E; Grigoriadis S; Katsinelos P
Ann N Y Acad Sci; 2019 Sep; 1452(1):12-17. PubMed ID: 31310338
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention in Barrett's Esophagus: Current Status.
Zeb MH; Baruah A; Kossak SK; Buttar NS
Gastroenterol Clin North Am; 2015 Jun; 44(2):391-413. PubMed ID: 26021201
[TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
[TBL] [Abstract][Full Text] [Related]
19. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.
Greene CL; Worrell SG; DeMeester TR
Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684
[TBL] [Abstract][Full Text] [Related]
20. Microbiome, innate immunity, and esophageal adenocarcinoma.
Baghdadi J; Chaudhary N; Pei Z; Yang L
Clin Lab Med; 2014 Dec; 34(4):721-32. PubMed ID: 25439272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
